You can buy or sell ICON plc and other stocks, options, ETFs, and crypto commission-free!
ICON plc Ordinary Shares, also called ICON plc, is a contract research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It operates through the following geographical segments: Ireland, Rest of Europe, United States, and Other. Read More The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
52 Week High
52 Week Low
Seeking AlphaFeb 25
ICON Acquires MolecularMD For Cancer Research Tech
The acquisition appears to be a logical and promising strategic move. With the deal, ICON gains the ability to offer a new line of services to the growing personalized cancer treatment space. ICON plc has announced the acquisition of MolecularMD for an undisclosed sum. Quick Take ICON plc (ICLR) has acquired MolecularMD for an undisclosed amount. MolecularMD [MMD] has developed a full service diagnostics service line to accelerate oncology (cancer) drug approval. With the deal for MMD, ICLR gains incr...
Seeking AlphaFeb 21
ICON plc (ICLR) CEO Steve Cutler on Q4 2018 Results - Earnings Call Transcript
ICON plc (NASDAQ:ICLR) Q4 2018 Earnings Conference Call February 21, 2019 9:00 AM ET Company Participants Jonathan Curtain - Vice President, Corporate Finance & Investor Relations Brendan Brennan - Chief Financial Officer Steve Cutler - Chief Executive Officer Conference Call Participants Dan Leonard - Deutsche Bank Ross Muken - Evercore ISI Jack Rogoff - Goldman Sachs Donald Hooker - KeyBanc Erin Wright - Credit Suisse Jack Meehan - Barclays David Windley - Jefferies Tejas Savant - JPMorgan J...
Yahoo FinanceFeb 20
Icon PLC (ICLR) Beats Q4 Earnings and Revenue Estimates
Icon PLC (ICLR) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.60 per share. This compares to earnings of $1.43 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 1.25%. A quarter ago, it was expected that this contract research organization would post earnings of $1.54 per share when it actually produced earnings of $1.54, delivering no surprise. Over the last four quarters, th...
Expected May 1, After Hours